10-Q Filing
Filing Information
| Form Type | 10-Q |
| Accession Number | 0001628280-23-016059 |
| Period End Date | 20230331 |
| Filing Date | 20230505 |
| Fiscal Year | 2023 |
| Fiscal Period | Q1 |
| XBRL Instance | jynt-20230331_htm.xml |
Filing Contents
This filing contains the following financial statements:
Balance Sheet
105 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$14.77M | USD | Point-in-time |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$18.25M | USD | Point-in-time |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$9.75M | USD | Point-in-time |
| Restricted cash |
RestrictedCashAndCashEquivalentsAtCarryingValue
|
$731.38K | USD | Point-in-time |
| Restricted cash |
RestrictedCashAndCashEquivalentsAtCarryingValue
|
$805.35K | USD | Point-in-time |
| Accounts receivable, net |
AccountsReceivableNetCurrent
|
$3.53M | USD | Point-in-time |
| Accounts receivable, net |
AccountsReceivableNetCurrent
|
$3.91M | USD | Point-in-time |
| Payroll liabilities ($0.9 million and $0.6 million attributable to VIE) |
EmployeeRelatedLiabilitiesCurrent
|
$3.57M | USD | Point-in-time |
| Deferred franchise and regional development costs, current portion |
ContractWithCustomerAssetNetCurrent
|
$1.06M | USD | Point-in-time |
| Deferred franchise and regional development costs, current portion |
ContractWithCustomerAssetNetCurrent
|
$1.05M | USD | Point-in-time |
| Payroll liabilities ($0.9 million and $0.6 million attributable to VIE) |
EmployeeRelatedLiabilitiesCurrent
|
$2.03M | USD | Point-in-time |
| Prepaid expenses and other current assets |
PrepaidExpenseAndOtherAssetsCurrent
|
$2.10M | USD | Point-in-time |
| Deferred revenue from company clinics attributable to VIE |
ContractWithCustomerLiabilityCurrent
|
$2.98M | USD | Point-in-time |
| Prepaid expenses and other current assets |
PrepaidExpenseAndOtherAssetsCurrent
|
$3.47M | USD | Point-in-time |
| Deferred revenue from company clinics attributable to VIE |
ContractWithCustomerLiabilityCurrent
|
$2.96M | USD | Point-in-time |
| Series A preferred stock, par value (in dollars per share) |
PreferredStockParOrStatedValuePerShare
|
$0.00 | USD | Point-in-time |
| Total current assets |
AssetsCurrent
|
$23.56M | USD | Point-in-time |
| Total current assets |
AssetsCurrent
|
$17.61M | USD | Point-in-time |
| Series A preferred stock, par value (in dollars per share) |
PreferredStockParOrStatedValuePerShare
|
$0.00 | USD | Point-in-time |
| Series A preferred stock, shares authorized (in shares) |
PreferredStockSharesAuthorized
|
50,000.00 | shares | Point-in-time |
| Property and equipment, net |
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
|
$17.50M | USD | Point-in-time |
| Property and equipment, net |
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
|
$17.48M | USD | Point-in-time |
| Series A preferred stock, shares authorized (in shares) |
PreferredStockSharesAuthorized
|
50,000.00 | shares | Point-in-time |
| Operating lease right-of-use asset |
OperatingLeaseRightOfUseAsset
|
$22.45M | USD | Point-in-time |
| Series A preferred stock, shares issued (in shares) |
PreferredStockSharesIssued
|
0.00 | shares | Point-in-time |
| Operating lease right-of-use asset |
OperatingLeaseRightOfUseAsset
|
$20.59M | USD | Point-in-time |
| Series A preferred stock, shares issued (in shares) |
PreferredStockSharesIssued
|
0.00 | shares | Point-in-time |
| Deferred franchise and regional development costs, net of current portion |
ContractWithCustomerAssetNetNoncurrent
|
$5.71M | USD | Point-in-time |
| Series A preferred stock, shares outstanding (in shares) |
PreferredStockSharesOutstanding
|
0.00 | shares | Point-in-time |
| Deferred franchise and regional development costs, net of current portion |
ContractWithCustomerAssetNetNoncurrent
|
$5.68M | USD | Point-in-time |
| Series A preferred stock, shares outstanding (in shares) |
PreferredStockSharesOutstanding
|
0.00 | shares | Point-in-time |
| Common stock, par value (in dollars per share) |
CommonStockParOrStatedValuePerShare
|
$0.00 | USD | Point-in-time |
| Common stock, par value (in dollars per share) |
CommonStockParOrStatedValuePerShare
|
$0.00 | USD | Point-in-time |
| Intangible assets, net |
IntangibleAssetsNetExcludingGoodwill
|
$11.91M | USD | Point-in-time |
| Intangible assets, net |
IntangibleAssetsNetExcludingGoodwill
|
$12.87M | USD | Point-in-time |
| Goodwill |
Goodwill
|
$8.49M | USD | Point-in-time |
| Goodwill |
Goodwill
|
$8.49M | USD | Point-in-time |
| Common stock, shares authorized (in shares) |
CommonStockSharesAuthorized
|
20.00M | shares | Point-in-time |
| Common stock, shares authorized (in shares) |
CommonStockSharesAuthorized
|
20.00M | shares | Point-in-time |
| Deferred tax assets |
DeferredIncomeTaxAssetsNet
|
$7.71M | USD | Point-in-time |
| Common stock, shares issued (in shares) |
CommonStockSharesIssued
|
14.56M | shares | Point-in-time |
| Deferred tax assets |
DeferredIncomeTaxAssetsNet
|
$8.44M | USD | Point-in-time |
| Common stock, shares issued (in shares) |
CommonStockSharesIssued
|
14.67M | shares | Point-in-time |
| Common stock, shares outstanding (in shares) |
CommonStockSharesOutstanding
|
14.64M | shares | Point-in-time |
| Common stock, shares outstanding (in shares) |
CommonStockSharesOutstanding
|
14.53M | shares | Point-in-time |
| Deposits and other assets |
DepositsAssetsNoncurrent
|
$756.39K | USD | Point-in-time |
| Deposits and other assets |
DepositsAssetsNoncurrent
|
$755.59K | USD | Point-in-time |
| Total assets |
Assets
|
$98.05M | USD | Point-in-time |
| Balance, beginning treasury stock (in shares) |
TreasuryStockCommonShares
|
32,035.00 | shares | Point-in-time |
| Balance, beginning treasury stock (in shares) |
TreasuryStockCommonShares
|
31,866.00 | shares | Point-in-time |
| Total assets |
Assets
|
$91.94M | USD | Point-in-time |
| Accounts payable |
AccountsPayableCurrent
|
$2.97M | USD | Point-in-time |
| Accounts payable |
AccountsPayableCurrent
|
$1.84M | USD | Point-in-time |
| Accrued expenses |
AccruedLiabilitiesCurrent
|
$2.00M | USD | Point-in-time |
| Accrued expenses |
AccruedLiabilitiesCurrent
|
$1.07M | USD | Point-in-time |
| Co-op funds liability |
CoOpFundsLiabilityCurrent
|
$805.35K | USD | Point-in-time |
| Co-op funds liability |
CoOpFundsLiabilityCurrent
|
$731.38K | USD | Point-in-time |
| Payroll liabilities ($0.9 million and $0.6 million attributable to VIE) |
EmployeeRelatedLiabilitiesCurrent
|
$3.57M | USD | Point-in-time |
| Payroll liabilities ($0.9 million and $0.6 million attributable to VIE) |
EmployeeRelatedLiabilitiesCurrent
|
$2.03M | USD | Point-in-time |
| Operating lease liability, current portion |
OperatingLeaseLiabilityCurrent
|
$5.62M | USD | Point-in-time |
| Operating lease liability, current portion |
OperatingLeaseLiabilityCurrent
|
$5.30M | USD | Point-in-time |
| Finance lease liability, current portion |
FinanceLeaseLiabilityCurrent
|
$24.43K | USD | Point-in-time |
| Finance lease liability, current portion |
FinanceLeaseLiabilityCurrent
|
$24.69K | USD | Point-in-time |
| Deferred franchise and regional developer fee revenue, current portion |
ContractWithCustomerLiabilityCurrent
|
$2.98M | USD | Point-in-time |
| Deferred franchise and regional developer fee revenue, current portion |
ContractWithCustomerLiabilityCurrent
|
$2.96M | USD | Point-in-time |
| Deferred revenue from company clinics ($4.9 million and $4.7 million attributable to VIE) |
DeferredRevenueFromCompanyClinicsCurrent
|
$7.47M | USD | Point-in-time |
| Deferred revenue from company clinics ($4.9 million and $4.7 million attributable to VIE) |
DeferredRevenueFromCompanyClinicsCurrent
|
$7.71M | USD | Point-in-time |
| Other current liabilities |
OtherLiabilitiesCurrent
|
$499.25K | USD | Point-in-time |
| Other current liabilities |
OtherLiabilitiesCurrent
|
$494.25K | USD | Point-in-time |
| Total current liabilities |
LiabilitiesCurrent
|
$24.97M | USD | Point-in-time |
| Total current liabilities |
LiabilitiesCurrent
|
$23.12M | USD | Point-in-time |
| Operating lease liability, net of current portion |
OperatingLeaseLiabilityNoncurrent
|
$18.67M | USD | Point-in-time |
| Operating lease liability, net of current portion |
OperatingLeaseLiabilityNoncurrent
|
$20.21M | USD | Point-in-time |
| Finance lease liability, net of current portion |
FinanceLeaseLiabilityNoncurrent
|
$63.51K | USD | Point-in-time |
| Finance lease liability, net of current portion |
FinanceLeaseLiabilityNoncurrent
|
$57.23K | USD | Point-in-time |
| Debt under the Credit Agreement |
LineOfCredit
|
$2.00M | USD | Point-in-time |
| Debt under the Credit Agreement |
LineOfCredit
|
$2.00M | USD | Point-in-time |
| Deferred franchise and regional developer fee revenue, net of current portion |
ContractWithCustomerLiabilityNoncurrent
|
$15.66M | USD | Point-in-time |
| Deferred franchise and regional developer fee revenue, net of current portion |
ContractWithCustomerLiabilityNoncurrent
|
$15.68M | USD | Point-in-time |
| Other liabilities |
OtherLiabilitiesNoncurrent
|
$27.23K | USD | Point-in-time |
| Other liabilities |
OtherLiabilitiesNoncurrent
|
$27.23K | USD | Point-in-time |
| Total liabilities |
Liabilities
|
$59.54M | USD | Point-in-time |
| Total liabilities |
Liabilities
|
$62.95M | USD | Point-in-time |
| Commitments and contingencies |
CommitmentsAndContingencies
|
- | USD | Point-in-time |
| Commitments and contingencies |
CommitmentsAndContingencies
|
- | USD | Point-in-time |
| Series A preferred stock, $0.001 par value; 50,000 shares authorized, 0 issued and outstanding, as of March 31, 2023 and December 31, 2022 |
PreferredStockValue
|
- | USD | Point-in-time |
| Series A preferred stock, $0.001 par value; 50,000 shares authorized, 0 issued and outstanding, as of March 31, 2023 and December 31, 2022 |
PreferredStockValue
|
- | USD | Point-in-time |
| Common stock, $0.001 par value; 20,000,000 shares authorized, 14,671,360 shares issued and 14,639,325 shares outstanding as of March 31, 2023 and 14,560,353 shares issued and 14,528,487 outstanding as of December 31, 2022 |
CommonStockValue
|
$14.67K | USD | Point-in-time |
| Common stock, $0.001 par value; 20,000,000 shares authorized, 14,671,360 shares issued and 14,639,325 shares outstanding as of March 31, 2023 and 14,560,353 shares issued and 14,528,487 outstanding as of December 31, 2022 |
CommonStockValue
|
$14.56K | USD | Point-in-time |
| Additional paid-in capital |
AdditionalPaidInCapital
|
$45.56M | USD | Point-in-time |
| Additional paid-in capital |
AdditionalPaidInCapital
|
$45.96M | USD | Point-in-time |
| Treasury stock 32,035 shares as of March 31, 2023 and 31,866 shares as of December 31, 2022, at cost |
TreasuryStockCommonValue
|
$859.28K | USD | Point-in-time |
| Treasury stock 32,035 shares as of March 31, 2023 and 31,866 shares as of December 31, 2022, at cost |
TreasuryStockCommonValue
|
$856.64K | USD | Point-in-time |
| Accumulated deficit |
RetainedEarningsAccumulatedDeficit
|
$-10.04M | USD | Point-in-time |
| Accumulated deficit |
RetainedEarningsAccumulatedDeficit
|
$-12.34M | USD | Point-in-time |
| Total The Joint Corp. stockholders' equity |
StockholdersEquity
|
$35.08M | USD | Point-in-time |
| Total The Joint Corp. stockholders' equity |
StockholdersEquity
|
$32.37M | USD | Point-in-time |
| Non-controlling Interest |
MinorityInterest
|
$25.00K | USD | Point-in-time |
| Non-controlling Interest |
MinorityInterest
|
$25.00K | USD | Point-in-time |
| Total equity |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$29.57M | USD | Point-in-time |
| Total equity |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$35.10M | USD | Point-in-time |
| Total equity |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$29.73M | USD | Point-in-time |
| Total equity |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$32.40M | USD | Point-in-time |
| Total liabilities and stockholders' equity |
LiabilitiesAndStockholdersEquity
|
$91.94M | USD | Point-in-time |
| Total liabilities and stockholders' equity |
LiabilitiesAndStockholdersEquity
|
$98.05M | USD | Point-in-time |
Income Statement
32 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Total revenues |
RevenueFromContractWithCustomerIncludingAssessedTax
|
$28.45M | USD | 1 Quarter |
| Total revenues |
RevenueFromContractWithCustomerIncludingAssessedTax
|
$22.44M | USD | 1 Quarter |
| Total cost of revenues |
CostOfRevenue
|
$2.31M | USD | 1 Quarter |
| Total cost of revenues |
CostOfRevenue
|
$2.62M | USD | 1 Quarter |
| Selling and marketing expenses |
SellingAndMarketingExpense
|
$4.16M | USD | 1 Quarter |
| Selling and marketing expenses |
SellingAndMarketingExpense
|
$3.29M | USD | 1 Quarter |
| Depreciation and amortization |
DepreciationAndAmortization
|
$2.34M | USD | 1 Quarter |
| Depreciation and amortization |
DepreciationAndAmortization
|
$1.63M | USD | 1 Quarter |
| General and administrative expenses |
GeneralAndAdministrativeExpense
|
$19.94M | USD | 1 Quarter |
| General and administrative expenses |
GeneralAndAdministrativeExpense
|
$15.38M | USD | 1 Quarter |
| Total selling, general and administrative expenses |
SellingGeneralAndAdministrativeExpense
|
$20.30M | USD | 1 Quarter |
| Total selling, general and administrative expenses |
SellingGeneralAndAdministrativeExpense
|
$26.44M | USD | 1 Quarter |
| Net loss on disposition or impairment |
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
|
$-6.91K | USD | 1 Quarter |
| Net loss on disposition or impairment |
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
|
$-65.47K | USD | 1 Quarter |
| Loss from operations |
OperatingIncomeLoss
|
$-176.43K | USD | 1 Quarter |
| Loss from operations |
OperatingIncomeLoss
|
$-678.24K | USD | 1 Quarter |
| Other income (expense), net |
OtherNonoperatingIncomeExpense
|
$-16.15K | USD | 1 Quarter |
| Other income (expense), net |
OtherNonoperatingIncomeExpense
|
$3.82M | USD | 1 Quarter |
| Income (loss) before income tax benefit |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
$3.14M | USD | 1 Quarter |
| Income (loss) before income tax benefit |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
$-192.57K | USD | 1 Quarter |
| Income tax expense |
IncomeTaxExpenseBenefit
|
$841.89K | USD | 1 Quarter |
| Income tax expense |
IncomeTaxExpenseBenefit
|
$13.22K | USD | 1 Quarter |
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total |
ProfitLoss
|
$-205.80K | USD | 1 Quarter |
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total |
ProfitLoss
|
$2.30M | USD | 1 Quarter |
| Basic (loss) earnings per share (in dollars per share) |
EarningsPerShareBasic
|
$-0.01 | USD | 1 Quarter |
| Basic (loss) earnings per share (in dollars per share) |
EarningsPerShareBasic
|
$0.16 | USD | 1 Quarter |
| Diluted (loss) earnings per share (in dollars per share) |
EarningsPerShareDiluted
|
$0.15 | USD | 1 Quarter |
| Diluted (loss) earnings per share (in dollars per share) |
EarningsPerShareDiluted
|
$-0.01 | USD | 1 Quarter |
| Basic weighted average shares (in shares) |
WeightedAverageNumberOfSharesOutstandingBasic
|
14.57M | shares | 1 Quarter |
| Basic weighted average shares (in shares) |
WeightedAverageNumberOfSharesOutstandingBasic
|
14.43M | shares | 1 Quarter |
| Diluted weighted average shares (in shares) |
WeightedAverageNumberOfDilutedSharesOutstanding
|
14.86M | shares | 1 Quarter |
| Diluted weighted average shares (in shares) |
WeightedAverageNumberOfDilutedSharesOutstanding
|
14.43M | shares | 1 Quarter |
Cash Flow Statement
65 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Net income (loss) |
NetIncomeLoss
|
$2.30M | USD | 1 Quarter |
| Net income (loss) |
NetIncomeLoss
|
$-205.80K | USD | 1 Quarter |
| Depreciation and amortization |
DepreciationDepletionAndAmortization
|
$2.34M | USD | 1 Quarter |
| Depreciation and amortization |
DepreciationDepletionAndAmortization
|
$1.63M | USD | 1 Quarter |
| Net loss on disposition or impairment (non-cash portion) |
GainLossOnDispositionOfAssets1
|
$-6.91K | USD | 1 Quarter |
| Net loss on disposition or impairment (non-cash portion) |
GainLossOnDispositionOfAssets1
|
$-65.47K | USD | 1 Quarter |
| Net franchise fees recognized upon termination of franchise agreements |
GainLossOnTerminationOfFranchisingAgreements
|
- | USD | 1 Quarter |
| Net franchise fees recognized upon termination of franchise agreements |
GainLossOnTerminationOfFranchisingAgreements
|
$73.09K | USD | 1 Quarter |
| Deferred income taxes |
DeferredIncomeTaxExpenseBenefit
|
$733.39K | USD | 1 Quarter |
| Deferred income taxes |
DeferredIncomeTaxExpenseBenefit
|
$-16.78K | USD | 1 Quarter |
| Stock based compensation expense |
ShareBasedCompensation
|
$266.21K | USD | 1 Quarter |
| Stock based compensation expense |
ShareBasedCompensation
|
$323.56K | USD | 1 Quarter |
| Accounts receivable |
IncreaseDecreaseInAccountsReceivable
|
$-385.63K | USD | 1 Quarter |
| Accounts receivable |
IncreaseDecreaseInAccountsReceivable
|
$-88.01K | USD | 1 Quarter |
| Prepaid expenses and other current assets |
IncreaseDecreaseInIncomeTaxesReceivable
|
$144.64K | USD | 1 Quarter |
| Prepaid expenses and other current assets |
IncreaseDecreaseInIncomeTaxesReceivable
|
$1.37M | USD | 1 Quarter |
| Deferred franchise costs |
IncreaseDecreaseInContractWithCustomerAsset
|
$27.25K | USD | 1 Quarter |
| Deferred franchise costs |
IncreaseDecreaseInContractWithCustomerAsset
|
$86.69K | USD | 1 Quarter |
| Deposits and other assets |
IncreaseDecreaseInDepositOtherAssets
|
$-801.00 | USD | 1 Quarter |
| Deposits and other assets |
IncreaseDecreaseInDepositOtherAssets
|
$94.88K | USD | 1 Quarter |
| Accounts payable |
IncreaseDecreaseInAccountsPayable
|
$-1.19M | USD | 1 Quarter |
| Accounts payable |
IncreaseDecreaseInAccountsPayable
|
$59.46K | USD | 1 Quarter |
| Accrued expenses |
IncreaseDecreaseInAccruedLiabilities
|
$818.78K | USD | 1 Quarter |
| Accrued expenses |
IncreaseDecreaseInAccruedLiabilities
|
$-164.75K | USD | 1 Quarter |
| Payroll liabilities |
IncreaseDecreaseInEmployeeRelatedLiabilities
|
$1.54M | USD | 1 Quarter |
| Payroll liabilities |
IncreaseDecreaseInEmployeeRelatedLiabilities
|
$-1.52M | USD | 1 Quarter |
| Deferred revenue |
IncreaseDecreaseInContractWithCustomerLiability
|
$288.36K | USD | 1 Quarter |
| Deferred revenue |
IncreaseDecreaseInContractWithCustomerLiability
|
$296.49K | USD | 1 Quarter |
| Other liabilities |
IncreaseDecreaseInOtherOperatingLiabilities
|
$280.16K | USD | 1 Quarter |
| Other liabilities |
IncreaseDecreaseInOtherOperatingLiabilities
|
$-57.73K | USD | 1 Quarter |
| Net cash provided by operating activities |
NetCashProvidedByUsedInOperatingActivities
|
$6.02M | USD | 1 Quarter |
| Net cash provided by operating activities |
NetCashProvidedByUsedInOperatingActivities
|
$447.88K | USD | 1 Quarter |
| Purchase of property and equipment |
PaymentsToAcquirePropertyPlantAndEquipment
|
$1.20M | USD | 1 Quarter |
| Purchase of property and equipment |
PaymentsToAcquirePropertyPlantAndEquipment
|
$1.29M | USD | 1 Quarter |
| Reacquisition and termination of regional developer rights |
ReacquisitionAndTerminationOfRegionalDeveloperRights
|
$250.00K | USD | 1 Quarter |
| Reacquisition and termination of regional developer rights |
ReacquisitionAndTerminationOfRegionalDeveloperRights
|
- | USD | 1 Quarter |
| Net cash used in investing activities |
NetCashProvidedByUsedInInvestingActivities
|
$-1.54M | USD | 1 Quarter |
| Net cash used in investing activities |
NetCashProvidedByUsedInInvestingActivities
|
$-1.20M | USD | 1 Quarter |
| Payments of finance lease obligation |
FinanceLeasePrincipalPayments
|
$6.01K | USD | 1 Quarter |
| Payments of finance lease obligation |
FinanceLeasePrincipalPayments
|
$21.39K | USD | 1 Quarter |
| Purchases of treasury stock under employee stock plans |
PaymentsForRepurchaseOfCommonStock
|
$2.64K | USD | 1 Quarter |
| Purchases of treasury stock under employee stock plans |
PaymentsForRepurchaseOfCommonStock
|
$2.60K | USD | 1 Quarter |
| Proceeds from exercise of stock options |
ProceedsFromStockOptionsExercised
|
$49.62K | USD | 1 Quarter |
| Proceeds from exercise of stock options |
ProceedsFromStockOptionsExercised
|
$138.46K | USD | 1 Quarter |
| Net cash provided by financing activities |
NetCashProvidedByUsedInFinancingActivities
|
$129.81K | USD | 1 Quarter |
| Net cash provided by financing activities |
NetCashProvidedByUsedInFinancingActivities
|
$25.64K | USD | 1 Quarter |
| Increase (decrease) in cash, cash equivalents and restricted cash |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
$-1.07M | USD | 1 Quarter |
| Increase (decrease) in cash, cash equivalents and restricted cash |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
$4.95M | USD | 1 Quarter |
| Cash, cash equivalents and restricted cash, beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$18.85M | USD | Point-in-time |
| Cash, cash equivalents and restricted cash, beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$19.91M | USD | Point-in-time |
| Cash, cash equivalents and restricted cash, beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$10.55M | USD | Point-in-time |
| Cash, cash equivalents and restricted cash, beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$15.50M | USD | Point-in-time |
| Cash, cash equivalents and restricted cash, end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$18.85M | USD | Point-in-time |
| Cash, cash equivalents and restricted cash, end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$19.91M | USD | Point-in-time |
| Cash, cash equivalents and restricted cash, end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$10.55M | USD | Point-in-time |
| Cash, cash equivalents and restricted cash, end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$15.50M | USD | Point-in-time |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$14.77M | USD | Point-in-time |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$18.25M | USD | Point-in-time |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$9.75M | USD | Point-in-time |
| Restricted cash |
RestrictedCash
|
$594.72K | USD | Point-in-time |
| Restricted cash |
RestrictedCash
|
$731.38K | USD | Point-in-time |
| Cash and cash equivalents and restricted cash |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$18.85M | USD | Point-in-time |
| Cash and cash equivalents and restricted cash |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$19.91M | USD | Point-in-time |
| Cash and cash equivalents and restricted cash |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$10.55M | USD | Point-in-time |
| Cash and cash equivalents and restricted cash |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$15.50M | USD | Point-in-time |
Stockholders Equity
26 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Balance, beginning common stock (in shares) |
CommonStockSharesOutstanding
|
14.64M | shares | Point-in-time |
| Balance, beginning common stock (in shares) |
CommonStockSharesOutstanding
|
14.53M | shares | Point-in-time |
| Balance, beginning |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$29.57M | USD | Point-in-time |
| Balance, beginning |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$35.10M | USD | Point-in-time |
| Balance, beginning |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$29.73M | USD | Point-in-time |
| Balance, beginning |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$32.40M | USD | Point-in-time |
| Balance, beginning treasury stock (in shares) |
TreasuryStockCommonShares
|
32,035.00 | shares | Point-in-time |
| Balance, beginning treasury stock (in shares) |
TreasuryStockCommonShares
|
31,866.00 | shares | Point-in-time |
| Stock-based compensation expense |
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
$323.56K | USD | 1 Quarter |
| Stock-based compensation expense |
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
$266.21K | USD | 1 Quarter |
| Issuance of restricted stock |
StockIssuedDuringPeriodValueRestrictedStockAwardGross
|
- | USD | 1 Quarter |
| Issuance of restricted stock |
StockIssuedDuringPeriodValueRestrictedStockAwardGross
|
- | USD | 1 Quarter |
| Exercise of stock options |
StockIssuedDuringPeriodValueStockOptionsExercised
|
$49.62K | USD | 1 Quarter |
| Exercise of stock options |
StockIssuedDuringPeriodValueStockOptionsExercised
|
$138.46K | USD | 1 Quarter |
| Purchases of treasury stock under employee stock plans |
TreasuryStockValueAcquiredCostMethod
|
$2.64K | USD | 1 Quarter |
| Purchases of treasury stock under employee stock plans |
TreasuryStockValueAcquiredCostMethod
|
$2.60K | USD | 1 Quarter |
| Net income (loss) |
ProfitLoss
|
$-205.80K | USD | 1 Quarter |
| Net income (loss) |
ProfitLoss
|
$2.30M | USD | 1 Quarter |
| Balance, ending common stock (in shares) |
CommonStockSharesOutstanding
|
14.64M | shares | Point-in-time |
| Balance, ending common stock (in shares) |
CommonStockSharesOutstanding
|
14.53M | shares | Point-in-time |
| Balance, ending |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$29.57M | USD | Point-in-time |
| Balance, ending |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$35.10M | USD | Point-in-time |
| Balance, ending |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$29.73M | USD | Point-in-time |
| Balance, ending |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$32.40M | USD | Point-in-time |
| Balance, ending treasury stock (in shares) |
TreasuryStockCommonShares
|
32,035.00 | shares | Point-in-time |
| Balance, ending treasury stock (in shares) |
TreasuryStockCommonShares
|
31,866.00 | shares | Point-in-time |
Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.